MASSDEVICE ON CALL — Conceptus (NSDQ:CPTS) intends to pursue an injunction against Hologic (NSDQ:HOLX) on the face of a recent legal win.
Earlier this week, a California jury awarded Conceptus $19 million and a 20 percent royalty in a patent spat over female sterilization technology.
The jury found that Hologic’s Adiana permanent contraception system infringed Conceptus’ patents for its Essure system.
Conceptus announced that it will seek an injunction to prevent Hologic from importing, using, selling or offering its system in the U.S., according to documents filed with the SEC.
Hospitalization post heart failure drops in the U.S.
Post-heart-failure hospitalization dropped 30 percent in the last decade among Medicare patients, CNBC.com reported.
House republicans submit device review legislation
House republicans submitted 10 new bills aimed at bolstering the FDA’s device review process by providing "solutions to improve the predictability, consistency, and transparency of FDA’s medical device review and approval process," BNA.com reported.
Experimental pain management device gets first-in-man implantation
SPR Therapeutics touted the world’s first implantation of its chronic pain management system in a 76-year-old man suffering from post-stroke shoulder pain for more than 10 years, according to a press release.
21-year-old battles health care reform in Missouri
A 21-year-old uninsured Missouri state resident took to the courts to argue against the legality of the individual insurance mandate, Law360.com reported.
